SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Stellantis N.V. - STLA

09.08.24 17:45 Uhr

Werte in diesem Artikel
Aktien

13,54 EUR -0,52 EUR -3,68%

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Stellantis N.V. ("Stellantis" or the "Company") (NYSE: STLA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Stellantis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On July 25, 2024, Stellantis issued a press release announcing its financial results for the first half of 2024. The Company reported a steep drop in earnings that fell below forecasts, citing weak margins and high inventory at its U.S. operations. In addition, Stellantis's Chief Executive Officer Carlos Tavares indicated that the Company was ready to dispose of underperforming brands in its portfolio, while Chief Financial Officer Natalie Knight disclosed the need to take "decisive actions to address operational challenges" in North America, including reducing production and prices for the Company's vehicles.

On this news, Stellantis's stock price fell $1.51 per share, or 7.7%, to close at $18.09 per share on July 25, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-stellantis-nv---stla-302218315.html

SOURCE Pomerantz LLP

Ausgewählte Hebelprodukte auf Stellantis

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Stellantis

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Stellantis

Analysen zu Stellantis

DatumRatingAnalyst
13:36Stellantis HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.09.2024Stellantis Market-PerformBernstein Research
04.09.2024Stellantis HoldJefferies & Company Inc.
03.09.2024Stellantis Market-PerformBernstein Research
28.08.2024Stellantis BuyUBS AG
DatumRatingAnalyst
28.08.2024Stellantis BuyUBS AG
28.08.2024Stellantis OverweightJP Morgan Chase & Co.
27.08.2024Stellantis BuyUBS AG
21.08.2024Stellantis BuyUBS AG
13.08.2024Stellantis BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
13:36Stellantis HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.09.2024Stellantis Market-PerformBernstein Research
04.09.2024Stellantis HoldJefferies & Company Inc.
03.09.2024Stellantis Market-PerformBernstein Research
07.08.2024Stellantis HoldJefferies & Company Inc.
DatumRatingAnalyst
31.07.2024Stellantis VerkaufenDZ BANK
07.05.2024Stellantis VerkaufenDZ BANK
16.02.2024Stellantis VerkaufenDZ BANK
15.10.2021Stellantis VerkaufenNorddeutsche Landesbank (Nord/LB)
03.03.2021Stellantis VerkaufenNorddeutsche Landesbank (Nord/LB)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Stellantis nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"